INTEGRA LIFESCIENCES HOLDINGS CORP Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $452.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2026-02-26
- INTEGRA LIFESCIENCES HOLDINGS CORP unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2014-12-31 was -$406.00K, a 106.09% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2014-09-30 was $1.60M.
- INTEGRA LIFESCIENCES HOLDINGS CORP unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2013-12-31 was $6.66M.
- INTEGRA LIFESCIENCES HOLDINGS CORP unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2013-09-30 was -$2.30M.
- INTEGRA LIFESCIENCES HOLDINGS CORP unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $452.00K, a 2052.38% increase from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $21.00K, a 92.31% decline from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $273.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2022 was $0.00.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 3 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 3 month as first filed | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 6 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 9 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 9 month as first filed | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $452.00K 10-K · filed 2026-02-26 | ||||||
| 2024-12-31 | $21.00K 10-K · filed 2026-02-26 | ||||||
| 2023-12-31 | $273.00K 10-K · filed 2026-02-26 | ||||||
| 2022-12-31 | $0.00 10-K · filed 2025-02-25 | ||||||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 | ||||||
| 2020-12-31 | $0.00 10-K · filed 2021-02-23 | ||||||
| 2019-12-31 | $0.00 10-K · filed 2021-02-23 | ||||||
| 2018-12-31 | $21.00K 10-K · filed 2021-02-23 | ||||||
| 2017-12-31 | $17.00K 10-K · filed 2020-02-21 | ||||||
| 2016-12-31 | $131.00K 10-K · filed 2019-02-26 | ||||||
| 2015-12-31 | $404.00K 10-K · filed 2018-03-01 | ||||||
| 2014-12-31 | -$406.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $1.19M derived: sum of 2 quarters · filed 2017-02-23 | $1.49M 10-K · filed 2017-02-23 | $1.58M 10-K · filed 2015-02-27 | |||
| 2014-09-30 | $1.60M 10-Q · filed 2015-11-04 | -$1.60M 10-Q · filed 2014-11-07 | $1.90M 10-Q · filed 2015-11-04 | -$2.00M 10-Q · filed 2014-11-07 | |||
| 2013-12-31 | $6.66M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $4.36M derived: sum of 2 quarters · filed 2016-02-26 | $3.16M 10-K · filed 2016-02-26 | $3.34M 10-K · filed 2014-02-27 | |||
| 2013-09-30 | -$2.30M 10-Q · filed 2014-11-07 | -$3.50M 10-Q · filed 2014-11-07 | |||||
| 2012-12-31 | $2.06M 10-K · filed 2015-02-27 | ||||||
| 2011-12-31 | $1.64M 8-K · filed 2014-06-20 | ||||||
| 2010-12-31 | $1.80M 10-K · filed 2013-02-26 | ||||||
| 2009-12-31 | $1.91M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |